Ken Flemming Hansen
Leamleder, Injectable Formulation And Process, Late Phase Development @ Novo
About Ken Flemming Hansen
Ken Flemming Hansen is a seasoned professional in the biotechnology sector, currently serving as Leamleder for Injectable Formulation and Process at Novo Nordisk. He has extensive experience in various roles at Chr. Hansen Holding A/S and holds a PhD in Experimental Cell Biology from the University of Southern Denmark.